1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Pallaghy, P.K. Norton, R.S. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C3 H8 N2 O S 120.173 n 2-AMINO-3-MERCAPTO-PROPIONAMIDE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C9 H11 N O3 181.189 D-TYROSINE D-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C5 H9 N O3 131.130 n 4-HYDROXYPROLINE HYDROXYPROLINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking US Biopolymers BIPMAA 0161 0006-3525 54 173 179 10.1002/1097-0282(200009)54:3<173::AID-BIP30>3.3.CO;2-1 10861378 The cyclic contryphan motif CPxXPXC, a robust scaffold potentially useful as an omega-conotoxin mimic. 2000 DTY A 4 HAS WRONG CHIRALITY AT ATOM CA 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 897.054 YNK-CONTRYPHAN 1 syn polymer no yes GC(HYP)(DTY)NPK(CY3) GCPYNPKC A polypeptide(L) n n n n n n n n database_PDB_caveat pdbx_entity_src_syn pdbx_struct_assembly pdbx_struct_oper_list struct_conn struct_ref struct_ref_seq repository Initial release Version format compliance Version format compliance Advisory Database references Derived calculations Source and taxonomy 1 0 2000-09-13 1 1 2008-04-27 1 2 2011-07-13 1 3 2020-06-24 _pdbx_entity_src_syn.ncbi_taxonomy_id _pdbx_entity_src_syn.organism_scientific _pdbx_entity_src_syn.pdbx_beg_seq_num _pdbx_entity_src_syn.pdbx_end_seq_num _struct_conn.pdbx_leaving_atom_flag RCSB Y RCSB 1999-10-19 REL THE SEQUENCE WAS DESIGNED TO MIMIC THE SURFACE OF W-CONOTOXIN GVIA FROM CONUS GEOGRAPHUS AND IS BASED ON THE CONTRYPHAN-R SCAFFOLD FROM CONUS RADIATUS 32630 synthetic construct sample 1 8 THIS STRUCTURE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR TECHNIQUES. LOWEST ENERGY 200 20 2D NOESY 0 3.5 AMBIENT 283 K STRUCTURES ARE BASED ON 104 NOES AND 2 PHI-ANGLES AND 4 CHI1-ANGLES. DISTANCE GEOMETRY SIMULATED ANNEALING 1 closest to the average 21 MM YNK-CONTRYPHAN BRUNGER refinement X-PLOR 3.5 600 Bruker DRX GLY 1 n 1 GLY 1 A CYS 2 n 2 CYS 2 A HYP 3 n 3 HYP 3 A DTY 4 n 4 DTY 4 A ASN 5 n 5 ASN 5 A PRO 6 n 6 PRO 6 A LYS 7 n 7 LYS 7 A CYS 8 n 8 CY3 8 A author_defined_assembly 1 monomeric A HYP 3 4-HYDROXYPROLINE A HYP 3 PRO A DTY 4 D-TYROSINE A DTY 4 TYR A CY3 8 2-AMINO-3-MERCAPTO-PROPIONAMIDE A CY3 8 CYS 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 A CA DTY 4 WRONG HAND 2 A CA DTY 4 WRONG HAND 3 A CA DTY 4 WRONG HAND 4 A CA DTY 4 WRONG HAND 5 A CA DTY 4 WRONG HAND 6 A CA DTY 4 WRONG HAND 7 A CA DTY 4 WRONG HAND 8 A CA DTY 4 WRONG HAND 9 A CA DTY 4 WRONG HAND 10 A CA DTY 4 WRONG HAND 11 A CA DTY 4 WRONG HAND 12 A CA DTY 4 WRONG HAND 13 A CA DTY 4 WRONG HAND 14 A CA DTY 4 WRONG HAND 15 A CA DTY 4 WRONG HAND 16 A CA DTY 4 WRONG HAND 17 A CA DTY 4 WRONG HAND 18 A CA DTY 4 WRONG HAND 19 A CA DTY 4 WRONG HAND 20 A CA DTY 4 WRONG HAND 1 18.20 2.70 111.00 129.20 A A A N CA C DTY DTY DTY 4 4 4 N 2 20.60 2.70 111.00 131.60 A A A N CA C DTY DTY DTY 4 4 4 N 4 19.20 2.70 111.00 130.20 A A A N CA C DTY DTY DTY 4 4 4 N 5 -13.89 1.90 113.40 99.51 A A A CA CB CG DTY DTY DTY 4 4 4 N 5 22.58 2.70 111.00 133.58 A A A N CA C DTY DTY DTY 4 4 4 N 6 19.87 2.70 111.00 130.87 A A A N CA C DTY DTY DTY 4 4 4 N 7 23.44 2.70 111.00 134.44 A A A N CA C DTY DTY DTY 4 4 4 N 8 20.67 2.70 111.00 131.67 A A A N CA C DTY DTY DTY 4 4 4 N 9 -18.84 1.90 113.40 94.56 A A A CA CB CG DTY DTY DTY 4 4 4 N 9 -4.54 0.60 121.00 116.46 A A A CB CG CD2 DTY DTY DTY 4 4 4 N 9 6.10 0.60 121.00 127.10 A A A CB CG CD1 DTY DTY DTY 4 4 4 N 9 21.65 2.70 111.00 132.65 A A A N CA C DTY DTY DTY 4 4 4 N 10 17.76 2.70 111.00 128.76 A A A N CA C DTY DTY DTY 4 4 4 N 11 21.48 2.70 111.00 132.48 A A A N CA C DTY DTY DTY 4 4 4 N 12 -16.32 1.90 113.40 97.08 A A A CA CB CG DTY DTY DTY 4 4 4 N 12 20.80 2.70 111.00 131.80 A A A N CA C DTY DTY DTY 4 4 4 N 13 -12.86 1.90 113.40 100.54 A A A CA CB CG DTY DTY DTY 4 4 4 N 13 20.45 2.70 111.00 131.45 A A A N CA C DTY DTY DTY 4 4 4 N 14 -12.31 1.90 113.40 101.09 A A A CA CB CG DTY DTY DTY 4 4 4 N 14 21.30 2.70 111.00 132.30 A A A N CA C DTY DTY DTY 4 4 4 N 15 17.73 2.70 111.00 128.73 A A A N CA C DTY DTY DTY 4 4 4 N 16 21.11 2.70 111.00 132.11 A A A N CA C DTY DTY DTY 4 4 4 N 17 19.04 2.70 111.00 130.04 A A A N CA C DTY DTY DTY 4 4 4 N 18 -11.65 1.90 113.40 101.75 A A A CA CB CG DTY DTY DTY 4 4 4 N 18 22.12 2.70 111.00 133.12 A A A N CA C DTY DTY DTY 4 4 4 N 19 19.14 2.70 111.00 130.14 A A A N CA C DTY DTY DTY 4 4 4 N 20 20.98 2.70 111.00 131.98 A A A N CA C DTY DTY DTY 4 4 4 N 1 A HYP 3 -70.01 -166.29 9 A HYP 3 -67.69 -176.47 12 A PRO 6 -80.66 31.28 15 A PRO 6 -69.55 13.45 16 A HYP 3 -56.29 -178.90 19 A PRO 6 -69.06 2.54 20 A PRO 6 -58.32 -8.36 YNK-CONTRYPHAN NMR STRUCTURE OF AN ENGINEERED CONTRYPHAN CYCLIC PEPTIDE (MOTIF CPXXPXC) 1 N N covale 1.317 both A CYS 2 A C CYS 2 1_555 A HYP 3 A N HYP 3 1_555 covale 2.023 none A CYS 2 A SG CYS 2 1_555 A CY3 8 A SG CY3 8 1_555 covale 1.304 both A HYP 3 A C HYP 3 1_555 A DTY 4 A N DTY 4 1_555 covale 1.307 both A DTY 4 A C DTY 4 1_555 A ASN 5 A N ASN 5 1_555 covale 1.310 both A LYS 7 A C LYS 7 1_555 A CY3 8 A N CY3 8 1_555 DE NOVO PROTEIN DISULFIDE BOND, D-HANDED, BETA TURN, CIS PROLINE, DE NOVO PROTEIN A CYS 2 A CYS 2 1 A HYP 3 A HYP 3 3.99 A CYS 2 A CYS 2 2 A HYP 3 A HYP 3 -5.17 A CYS 2 A CYS 2 3 A HYP 3 A HYP 3 -2.73 A CYS 2 A CYS 2 4 A HYP 3 A HYP 3 9.69 A CYS 2 A CYS 2 5 A HYP 3 A HYP 3 -4.02 A CYS 2 A CYS 2 6 A HYP 3 A HYP 3 0.75 A CYS 2 A CYS 2 7 A HYP 3 A HYP 3 9.15 A CYS 2 A CYS 2 8 A HYP 3 A HYP 3 10.58 A CYS 2 A CYS 2 9 A HYP 3 A HYP 3 3.58 A CYS 2 A CYS 2 10 A HYP 3 A HYP 3 10.60 A CYS 2 A CYS 2 11 A HYP 3 A HYP 3 -10.88 A CYS 2 A CYS 2 12 A HYP 3 A HYP 3 10.72 A CYS 2 A CYS 2 13 A HYP 3 A HYP 3 2.58 A CYS 2 A CYS 2 14 A HYP 3 A HYP 3 -9.27 A CYS 2 A CYS 2 15 A HYP 3 A HYP 3 11.08 A CYS 2 A CYS 2 16 A HYP 3 A HYP 3 -10.59 A CYS 2 A CYS 2 17 A HYP 3 A HYP 3 -8.01 A CYS 2 A CYS 2 18 A HYP 3 A HYP 3 11.86 A CYS 2 A CYS 2 19 A HYP 3 A HYP 3 9.41 A CYS 2 A CYS 2 20 A HYP 3 A HYP 3 -8.52 1D7T PDB 1 1 1D7T 1 8 1D7T 1 8 1D7T A 1 1 8 1 P 1